The Effect of Red-Yeast-Rice Supplement on Serum Lipid Profile and Glucose Control in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance.
- Author:
Mi Ran KANG
1
;
Ji Young KIM
;
Yae Jung HYUN
;
Hyae Jin KIM
;
Hyun Yang YEO
;
Young Duk SONG
;
Jong Ho LEE
Author Information
1. Interdisciplinary Program: Science for Aging, Yonsei University, Seoul 120-749, Korea.
- Publication Type:Original Article ; Randomized Controlled Trial
- Keywords:
red-yeast-rice;
monacolin K;
serum lipid profile;
glucose control;
double-blind/placebo-controlled study
- MeSH:
Biological Agents;
Blood Glucose;
Cholesterol, HDL;
Cholesterol, LDL;
Fasting;
Glucose;
Hemoglobins;
Insulin;
Lovastatin;
Yeasts
- From:The Korean Journal of Nutrition
2008;41(1):31-40
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This study was aimed at evaluating the effect of red-yeast-rice supplementation on cholesterol-lowering and glucose control in subjects with impaired fasting glucose (IFT) or impaired glucose tolerance (IGT). We conducted a doubleblind, placebo-controlled study with 3 groups ; placebo, low dose group (red yeast rice 210.0 mg/capsule, 2.52 g/day)and high dose group (red yeast rice 420.0 mg/capsule, 5.04 g/day), which were randomly assigned to subjects with impaired fasting glucose or impaired glucose tolerance. We measured fasting serum concentrations of total-, LDL-, HDL-cholesterol, triglyceride, glucose, insulin, free fatty acid (FFA) and 2 h oral glucose tolerence test (OGTT) before and after the supplementation. Both low dose and high dose groups had significant decrease in LDL cholesterol and atherogenic index (AI) compared with placebo group (p < 0.05). Additionally, total and HDL cholesterol improved significantly in high dose group compared with placebo group (p < 0.05). Fasting serum glucose decreased in test groups and increased in placebo group after intervention. However, it was not significant differences. In subjects which fasting blood glucose is more than 110 mg/dL, fasting glucose had a tendency to decrease in high dose group (p < 0.1) and Hemoglobin A1c (HbA1c) had significant decrease in low dose group (p < 0.05), while insulin and HOMA-IR had a tendency to increase in placebo group after intervention. Mean changes of glucose related parameters (fasting glucose, insulin, HOMA-IR) compared with placebo group did not show significant differences. In conclusion, subjects with impaired fasting glucose or impaired glucose tolerance were significantly improved in serum lipid profile by red yeast rice supplementation without serious side effects. These are more effective in the case of a high dose. The effects of red yeast rice supplementation on glucose control were insignificant.
